FARMACIA Y TECNOLOGÍA FARMACÉUTICA
Saila
Pfizer (United States)
Nueva York, Estados UnidosPfizer (United States)-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2007
-
Economic evaluation of voriconazole versus caspofungin for the treatment of invasive aspergillosis in Spain
Clinical Drug Investigation, Vol. 27, Núm. 3, pp. 197-205